Consumption of inorganic arsenic in drinking water at high levels has been associated with chronic diseases. Research groups have estimated historic exposure using databases and models of arsenic in drinking water supplies, along with participant residential histories. Urinary arsenic species are an established biomarker of recent exposure; we compare arsenic concentrations in historically collected urine samples with predicted estimates of arsenic exposure. Using a cohort of 462 subjects with at least one urine sample collected from 1984-1992 and an arsenic exposure estimate through drinking water at the time of the urine sample, individual exposure estimates were compared with speciated urine arsenic (UAs) concentrations using correlation and multiple regression analyses. Urine inorganic arsenic (UIAs) concentrations (trivalent arsenic, pentavalent arsenic, monomethylarsonic acid, dimethylarsonic acid) were best predicted by residential water arsenic concentrations (R 2 ¼ 0.3688), compared with metrics including water consumption (R 2 ¼ 0.2038) or water concentrations at employment locations (R 2 ¼ 0.2331). UIAs concentrations showed similar correlation when stratified by whether the arsenic concentration was predicted or measured. Residential water arsenic concentrations, independent of water intake or water concentrations at places of employment, best explain the variability in UIAs concentrations, suggesting historical reconstruction of arsenic exposure that accounts for space-time variability and water concentrations may serve as a proxy for exposure.
INTRODUCTION
Arsenic, specifically inorganic arsenic, is a ubiquitous metal found throughout the earth in air, water, and soil. Inorganic arsenic is a well-documented environmental and occupational contaminant with great public health implications. [1] [2] [3] [4] [5] [6] [7] [8] It has been a well-known poison at very high concentrations (100 mg) and was first identified as an occupational toxicant in the mining industry in the late 1800s. 9 In 1942, the Environmental Protection Agency first mandated inorganic arsenic as an environmental contaminant by setting the maximum contaminant level in water to 50 mg/l. 1 In 1962, the United States Public Health Service recommended a drinking water limit for inorganic arsenic at 10 mg/l based on long-term health concerns (cardiovascular system); 10 however, this was not adopted as part of the Safe Water Drinking Act until 2006. 1, [11] [12] [13] Inorganic arsenic exposure through drinking water continues to be the predominant route for exposure, and its widespread occurrence throughout the world and in the United States makes it a priority environmental health concern.
A key challenge in investigating the association between inorganic arsenic exposure and chronic disease is in the exposure reconstruction over potentially long periods. Biomarkers of both inorganic and organic arsenic exposure (e.g., urine, toenails, hair, blood) reflect recent exposure. Urine arsenic (UAs) concentrations are indicative of exposure (inorganic and organic) within the past 3 days, which is inadequate for assessing cumulative exposure relevant to the development of chronic diseases.
14 UAs measurements include both inorganic and organic forms specifically arsenosugars ingested from seafood, which have been shown to be non-toxic. 2 Speciating UAs concentrations into inorganic species and metabolites and organic forms allows investigators greater sensitivity to linking UAs with inorganic arsenic intake, [15] [16] [17] [18] [19] which is primarily from drinking water in areas where water arsenic exceeds 10 mg/l. 20, 21 The inorganic species and the methylated metabolites dimethylarsonic acid (DMA) and monomethylarsonic acid (MMA) are quantified to reflect exposure to inorganic arsenic. 22 The use of biological samples such as urine are preferred in that they are most likely to represent the biological dose; however, without repeated samples over a long period of time, or historically collected samples, it is impossible to use biomarkers to characterize chronic exposure to arsenic.
In high-exposure areas (Arsenic 4100 mg/l), epidemiological studies using relatively simple exposure estimates have identified associations with diabetes mellitus (DM), coronary heart disease, and a host of other health outcomes. [3] [4] [5] [6] However, studies have faced considerable more difficulty yielding conclusive results at lower levels of exposure, where more complicated exposure estimates have been developed to account for changes in arsenic concentrations and participant sources of drinking water over time. 2, [4] [5] [6] [7] [8] 23, 24 Weaker and less consistent results may be due, in part, to errors in the exposure assessment.
We present a study designed to compare estimates of past arsenic exposure with UAs levels assessed at the same point in time. Speciated UAs measurements from the 1980s are compared with estimates of arsenic exposure from drinking water during the same time period. This work will help guide selection of the most suitable exposure metric for epidemiological studies of chronic diseases and low-level arsenic exposure.
METHODS

Study Area
The San Luis Valley (SLV), located in the south central region of Colorado, is the largest mountain desert in North America and extends from south central Colorado into northern New Mexico. The SLV is 75-kilometers wide and 160-kilometers long with an average elevation of 7770 feet. The SLV is part of the Rio Grande Rift System bordered by the San Juan mountain range to the north and west, the Sangre de Cristo and Culebra mountain ranges to the east, and the Rio Grande Alluvial Fan to the south. Arsenic contamination in the SLV naturally occurs due to snowmelt, and leaching from geological formations and mountains.
Study Population
We report on exposure to inorganic arsenic in drinking water in 462 participants of the San Luis Valley Diabetes Study (SLVDS). The SLVDS is a population-based cohort study of risk factors for DM and other related chronic diseases among Hispanic and non-Hispanic whites ages 20-74 at baseline, who were residents of Alamosa and Conejos Counties in south central Colorado. Study participant recruitment and data collection methods have been previously described. 25 In brief, between 1984 and 1998, researchers at the University of Colorado recruited subjects and collected clinical, behavioral, and demographic data and made serial diagnostic assessments. 25 Between 1984 and 1988 participants underwent a baseline clinic visit followed by two clinic visits after the baseline visit between 1988 and 1998. Urine samples were collected at the baseline and follow-up visits between 1984 and 1992. The population for the present study was selected from a case-cohort study of DM and coronary heart disease. The participant cohort included 462 individuals who at their baseline had no known history of coronary heart disease events or DM diagnosis, and had a corresponding urine sample collected at their baseline and/or follow-up visit.
UAs Concentrations
Spot urine samples (B120 ml) were collected during the clinic visits as part of SLVDS (between 1984 and 1991). Random spot UAs sample concentrations are highly correlated with 24-hour sample arsenic concentrations, indicating a daily steady state for arsenic and suitability of random spot urine samples in analysis. 16, 26 Samples were aliquoted into tubes and stored in a negative 80 1C freezer. In 2003, the samples were transported to the Colorado State Department of Public Health and Environment chemistry laboratory and were stored in a negative 80 1C freezer where they remained until analysis in 2008.
Laboratory methods met both Clinical Laboratory Improvement Amendment and Environmental Protection Agency standards for quality assurance, which included an inductively coupled argon plasma instrument with a mass spectrometer as the detection system with a detection limit of one part in ten. 19 In the United States, urine inorganic arsenic (UIAs) and its metabolites are generally below 10 mg/l. 27 A quantitative analysis of arsenic metabolites (termed arsenic speciation) was conducted on the historically collected urine samples from the SLVDS to measure inorganic arsenic species and metabolites (trivalent arsenic, pentavalent arsenic, MMA, and DMA) and AB. Arsenic speciation clarifies possible dietary contribution to total arsenic in urine and potential interference of AB in association studies. 22 Samples were analyzed using the enzyme multiplied immunoassay technique (detection limit of 10 mg/dl) for urine creatinine concentrations at time of UAs analysis to adjust for degree of dilution of the urine sample.
Arsenic Exposure Estimates
Participants selected for this study had between two and three clinic visits during the SLVDS study period of 1984 and 1998 in which demographic, behavioral, clinical, and physiological data were collected. These data were used in conjunction with new data collected recently (2007-2009) through a structured in person interview to create an arsenic exposure matrix for each subject. In the recent interview, participants were asked about past residences and workplace/schooling locations and history of drinking water consumption at each location. Water samples (n ¼ 357) were collected from the tap reported as usually used to supply household drinking water during the time of the interview (2007-2009). The samples were transported to the chemistry laboratory of the Colorado Department of Public Health and Environment for analysis. None of the participants reported use of water treatment devices at their residence during the study period. At the time of the sample, subjects were asked whether the water source was a private well or public water, and if it was public water then which water district was the supplier. Lastly, geographical coordinates were identified with a global positioning system unit for all water samples collected at houses supplied by private wells.
At the chemistry laboratory, water samples were analyzed for a full metals panel that included 17 metals including arsenic, using a standard ion chromatography coupled with inductively coupled plasma mass spectrometry. Inductively coupled plasma mass spectrometry is a premier analytical method, approved by the Environmental Protection Agency (Method 1638). Quality control procedures were implemented to ensure accuracy and precision of measurements. These included calibration standards prepared each day assays were performed, reagent blanks, and duplicate, spike, and certified standards. Results were reported as total arsenic in micrograms per liter (mg/l) with a detection limit of 1 mg/l.
Estimates of arsenic concentration in drinking water were developed for those individuals who changed residences between the time of urine collection and the time of tap water collection, as well as for locations of employment. Methods and findings specific to the temporal and spatial characterization of groundwater inorganic arsenic concentrations in the SLV, and the exposure reconstruction effort are presented in detail elsewhere. 28 In brief, using repeated samples of historical groundwater measurements, we found that naturally occurring inorganic arsenic concentrations in groundwater are stable over long periods of time (samples collected 1-5 years apart: r ¼ 0.87; 5-10 years apart: r ¼ 0.89; 10-15 years apart: r ¼ 0.89; 15-25 years apart: r ¼ 0.88), consistent with other studies. 29 The spatial variability of inorganic arsenic concentrations in groundwater was characterized using Ordinary Kriging methods involving 595 water quality samples; arsenic concentrations were predicted at locations of past private wells. We validated the geospatial modeling using a correlation analysis in a 10% randomly selected validation sample of observed and predicted values (r ¼ 0.715; 95% CI ¼ 0.67, 0.75). For public water supplies, each community water supply was assigned the mean arsenic concentration specific to that water supply except for water in the city of Alamosa, Colorado, as that supply was derived from several different wells. An analysis of variance found significant variability within that system by street and sector (Po0.0001). The arsenic concentration for past residential and employment locations that utilized Alamosa public water was therefore defined as the mean arsenic concentration found in that street and sector.
In summary, residential inorganic arsenic concentration at the time the urine sample was collected was assigned the measured value if living at same location at times of urine and water collection (N ¼ 204); or the predicted concentration based on the geospatial model for private wells (N ¼ 125) or public water estimate for community supplies (N ¼ 133). Three metrics of inorganic arsenic exposure through drinking water were developed: Metric 1 was residential arsenic concentration (mg/l) in drinking water; Metric 2 was the residential dose (mg/day) defined as the residential arsenic concentration in drinking water (mg/l) multiplied by the selfreported amount of water consumed at residence at that time (l/day); and Metric 3 is total dose (mg/day) defined as the residential arsenic dose (Metric 2) plus the arsenic dose at work or school.
Statistical Analysis
UAs species included (in mg/dl) trivalent arsenic, pentavalent arsenic, MMA, DMA, and an aggregate arsenic measurement defined as the sum of trivalent arsenic, pentavalent arsenic, MMA, and DMA to represent the inorganic species in urine and its metabolites (herein UIAs). Also calculated were creatinine corrected concentrations of total arsenic and the UIAs concentrations (in mg/g creatinine). UAs concentrations less than the detection limit were listed as the detection limit divided by the square root of two.
UAs species and estimated arsenic exposures did not have normal distributions and were log base 10 transformed. Descriptive statistics were calculated for estimated arsenic exposure and UAs concentrations. Mean values for urinary arsenic metrics were compared across gender and smoking status (current smoker/not) with a Student's t test. A Spearman correlation analysis was performed to determine the linear association between urinary arsenic concentrations and age and BMI.
Spearman correlation analyses were used to determine the linear association between the UIAs urinary concentrations corrected for urine creatinine concentrations (mg/g) and each of the three estimates of inorganic arsenic exposure in drinking water (residential concentration, residential dose, and total dose). These results were presented in scatter plots of the values. Three separate multivariate regression models were used to test the association between each of the three estimates of arsenic exposure through drinking water and the UIAs concentrations while controlling for gender, age, ethnicity, BMI, smoking status (current/not current), and urine creatinine levels. Research by Barr et al. 30 recommends not adjusting the UAs analyte for creatinine in the exposure measure, but instead to include creatinine levels as a covariate to allow for adjustment for creatinine and the significance of other variables to be independent of creatinine.
Regression models were repeated in a subset of the sample (N ¼ 204) that did not move between urine collection (1984-1992) and drinking water collection (2007) (2008) (2009) . UIAs is regressed on (a) arsenic exposure predicted at time of urine collection and (b) arsenic measured in drinking water. Regressions were repeated in subsets with arsenic predicted from private well spatial model (N ¼ 101), and those with arsenic estimated from historical public supply data set (N ¼ 103). Finally, regression models were repeated in a subset limited to home arsenic concentrations estimated at least 2 mg/l (N ¼ 303), and in a subset defined by those with water intake greater than six cups/day (median value, 1.5 l; N ¼ 215).
RESULTS
Fifty-two percent of the cohort was male, 54% was White nonHispanic (46% Hispanic), and 72% were not current smokers at time of urine collection. The mean age was 57 years at time of urine collection with a range of 34-80 years and the mean BMI was 26.8 kg/m 2 . UAs concentrations ranged from 4.0 to 521.0 mg/dl with a geometric mean of 16.9 mg/dl. These values were higher than the national average as depicted by data from NHANES (Table 1) . UAs concentrations corrected for creatinine levels ranged from 5.0 to 212.1 mg/g creatinine with a geometric mean of 20.0 mg/g creatinine. These values were also higher than the national average, as expected given the SLV is a region of elevated drinking water arsenic concentrations. Table 2 presents mean arsenic concentrations of different urinary species in relation to estimated water arsenic concentrations. In general, concentrations of urinary arsenic species increased with water arsenic concentrations; DMA was the largest contributor to urinary arsenic concentrations. In a separate analysis, the three arsenic exposure metrics were significantly correlated with the UIAs concentration corrected for creatinine with residential concentration having the strongest correlation (r ¼ 0.55). Residential dose (r ¼ 0.37) and dose at home and work (r ¼ 0.39) were less correlated with the UIAs measure. Neither age, gender, ethnicity, BMI, nor water were significantly correlated with any UAs measure (P40.05); however, current smoking showed a weak but significant correlation with UIAs (r ¼ 0.12; P ¼ 0.008). In three separate models, we separately regressed each arsenic exposure estimate with the UIAs corrected for creatinine (mg/g), and found that residential arsenic concentrations best explained the variability in the UIAs (R 2 ¼ 0.3688), compared with metrics which also includes water consumption (R 2 ¼ 0.2038) or water arsenic exposure at employment locations (R 2 ¼ 0.2331). Next we directly compared different methods of estimating arsenic concentration in drinking water with the UIAs measure corrected for creatinine (mg/g) ( Table 3) Abbreviations: AB, arsenobetaine; As 3 þ , trivalent arsenic; As 5 þ , pentavalent arsenic; C-UAs, corrected urine arsenic levels (mg arsenic/g of creatinine); DMA, dimethylarsonic acid; MMA, monomethylarsonic acid; UAs, urine arsenic mg/l; UIAs, inorganic urine arsenic levels. a UAs includes 72 samples with total UAs values %2.0 mg/dl, which were not speciated as total levels were very low.
DISCUSSION
We documented associations separately between several exposure metrics and historical UIAs measurement, with the strongest association for the metric that only included residential arsenic concentration in drinking water. We also found that this association between water inorganic arsenic concentration and the UIAs species was similarly strong for measured or predicted water arsenic concentrations. This suggests that exposure reconstruction using historical data and spatial/temporal models of residential arsenic concentrations in drinking water is a good indication of the relevant inorganic arsenic exposure as represented by urinary arsenic concentrations, at least in this study area where spatial models for predicting arsenic concentration are well-validated.
The predictability of inorganic arsenic concentration in residential drinking water on UAs species has been documented in areas with high arsenic (4 100 mg/l) concentrations in drinking water. [31] [32] [33] [34] In Bangladesh and India where arsenic concentrations are high, studies have found significant correlation between urinary arsenic and inorganic arsenic in drinking water (Bangladesh: r ¼ 0.75; Po0.0001 and India r ¼ 0.86; Po0.0001). Mandal et al. 35, 36 further limited the analysis to a subcohort with water arsenic o50 mg/l, leading to a correlation of r ¼ 0.86 (Po0.0001). In our lower arsenic region, we also report an association between UAs and water arsenic (P ¼ 0.55; Po0.0001). Our findings used a measure of UAs species (iAs þ MMA þ DMA ¼ UIAs) suggested to be a better indicator of exposure to inorganic arsenic in drinking water compared with total UIAs (Apostoli et al. 37 ). UIAs excludes the noise due to non-toxic dietary arsenic contribution (e.g., AB). Our findings, along with others from the United States, 16, 19 suggest that even at low arsenic levels in drinking water, there is a significant correlation with inorganic urinary arsenic species.
Our results also indicate that residential arsenic concentrations, as opposed to exposure estimates based on water intake or employment locations, best explain the variability in urinary arsenic concentrations, which is supported by Rivera-Nunez, et al. 19 We think this finding is attributed to greater error in exposure when including estimates of water intake and of arsenic at employment locations. Rivera-Nunez et al. 19 showed an improvement in the association when the analysis was limited to subjects with high water intake (41.5 l/day); we did not replicate this finding that might be due to our cohort being older and therefore having lower reliability in recall of water intake.
In a stratified analysis of predicted and measured water arsenic concentrations we show that measured and predicted arsenic levels in drinking water were similarly correlated with UAs concentrations. As the measurements were made in water samples collected in 2007-2009 and correlated with urine samples collected in 1984-1992, this temporal mismatch could contribute to the comparable correlation estimate for UAs with predicted vs measured water arsenic values, but we and others have documented strong temporal correlation (r ¼ 0.88; Po0.001) of arsenic measurements in well water over or up to a 20-year period, suggesting the timing of measurement should only have a minor effect. Further, the reasonably strong association between UIAs and arsenic concentrations in drinking water suggests that the predictive model is a solid proxy for estimating exposure in the SLV. These findings suggest that the use of geospatial models to predict arsenic concentrations in groundwater 28 may be a viable approach for predicting arsenic exposure in geographic areas where spatial model performance is strong (e.g., r ¼ 0.72, P ¼ 0.0013 in groundwater arsenic validation data set).
Past research has indicated that there can be confounding factors affecting the association between inorganic arsenic concentration in water and concentrations of UIA species. We controlled for urine dilution by including urinary creatinine concentrations as separate independent variables in our regression models as suggested by Gamble and Liu. 38 Past research has suggested that hormones may affect arsenic methylation, and our findings did find gender was a significant confounder and included in the regression models as an independent variable 39 Current smoking status was also included in the regression model and was significantly associated with UIAs likely due to inorganic arsenic exposure from tobacco smoking (REF) . Other factors such as race/ethnicity, BMI, and age were included in the regression model but were not associated with UIAs and showed little influence on the results.
A potential limitation of our study is that we only accounted for inorganic arsenic exposure through drinking water and did not consider arsenic intake from food or inhalation. Numerous studies have shown that arsenic in drinking water is by far the major determinant of overall inorganic arsenic exposure in populations such as the SLV where drinking water arsenic concentrations are moderately elevated. 21, 40, 41 Therefore, we feel that our method has accounted for the major route of exposure to arsenic in this population. Another potential limitation is that urinary AB (considered less toxic than inorganic arsenic and its metabolites) can contribute to DMA concentrations; 42 however, this degree of confounding is expected to be minimal, 16 especially in this population that has low seafood intake.
There also is an unknown impact of long-term storage on UAs concentrations. Our samples were stored for as long as 25 years in the best possible conditions for preservation (secured, locked, and unlit À 20 and À 80 1C freezer; personal correspondence, Dr. Jorg Feldmann, 2009); however, past research has not determined the effects of such long-term storage on results. To characterize the potential influence of long-term storage on urine metabolites, we compared urine creatinine concentrations measured at the time of the baseline visit (1984) (1985) (1986) (1987) (1988) with creatinine concentrations measured in the same sample after being frozen for 25 years (2008). Results suggest a significant correlation between the two measurements (r ¼ 0.8743), which is supported by other research in the United States. 41 It is expected that there is potential for underestimation of arsenic species due to oxidation; however, there is no evidence that this would be differential across subjects. Further, there were 26 participants with two urine samples collected at least 2 years apart that were analyzed for UAs and creatinine concentrations. We found a strong correlation between the UAs levels corrected for creatinine (mg/g; r ¼ 0.8053) for the paired samples, indicating that independent of intra-individual variation, creatinine and arsenic concentrations were highly correlated.
In conclusion, we found that residential water arsenic concentrations best explain the variability in urinary arsenic concentrations. Our predictive model for estimating historic water arsenic concentrations shows strong correlation with UIAs, suggesting our modeling approach is useful for estimating arsenic exposure in Table 3 . Correlation between the sum of urinary arsenic species (As 3 þ , As 5 þ , MMA, DMA) (mg/dl) and stratified estimates of arsenic concentration in home drinking water (mg/l). 
Stratification
